$8.13
0.212.65%
Ultimo aggiornamento: Nov 19, 2:53 PM
Comments
Loading...
PanoramicaNotizieUtiliValutazioni degli analistiInsider trading
Vendite allo scoperto
Rapporto azionarioReport sulle vendite allo scoperto
Il short interest su Aligos Therapeutics Inc (NASDAQ:ALGS) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 235.01K a 227.28K. Questo rappresenta il 4.34% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 93.26K azioni scambiate al giorno, ci vorrebbero 2.44 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
227.28K
Vendite allo scoperto %
4.34%
Giorni di copertura
2.44
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ALGS | Aligos Therapeutics, Inc. Comm | 10/31/2025 | 11/11/2025 | 4.34% | 5,239,688 | 227,276 | 93,262 | 2.44 | |
ALGS | Aligos Therapeutics, Inc. Comm | 10/15/2025 | 10/24/2025 | 3.89% | 6,037,480 | 235,005 | 97,157 | 2.42 | |
ALGS | Aligos Therapeutics, Inc. Comm | 09/30/2025 | 10/09/2025 | 4.52% | 6,037,480 | 272,621 | 76,792 | 3.55 | |
ALGS | Aligos Therapeutics, Inc. Comm | 09/15/2025 | 09/24/2025 | 4.84% | 6,037,480 | 292,427 | 50,501 | 5.79 | |
ALGS | Aligos Therapeutics, Inc. Comm | 08/29/2025 | 09/10/2025 | 5.17% | 6,037,480 | 312,192 | 99,071 | 3.15 | |
ALGS | Aligos Therapeutics, Inc. Comm | 08/15/2025 | 08/26/2025 | 5.01% | 6,037,480 | 302,609 | 57,904 | 5.23 | |
ALGS | Aligos Therapeutics, Inc. Comm | 07/31/2025 | 08/11/2025 | 5.99% | 6,037,480 | 361,738 | 72,359 | 5 | |
ALGS | Aligos Therapeutics, Inc. Comm | 07/15/2025 | 07/24/2025 | 7.53% | 5,200,907 | 391,884 | 91,185 | 4.3 | |
ALGS | Aligos Therapeutics, Inc. Comm | 06/30/2025 | 07/10/2025 | 10.25% | 5,200,907 | 533,025 | 97,183 | 5.48 | |
ALGS | Aligos Therapeutics, Inc. Comm | 06/13/2025 | 06/25/2025 | 10.42% | 5,200,907 | 542,118 | 162,100 | 3.34 | |
ALGS | Aligos Therapeutics, Inc. Comm | 05/30/2025 | 06/10/2025 | 10.63% | 5,200,907 | 552,791 | 118,486 | 4.67 | |
ALGS | Aligos Therapeutics, Inc. Comm | 05/15/2025 | 05/27/2025 | 12.31% | 5,200,907 | 640,196 | 197,756 | 3.24 | |
ALGS | Aligos Therapeutics, Inc. Comm | 04/30/2025 | 05/09/2025 | 16.07% | 5,200,907 | 835,744 | 99,759 | 8.38 | |
ALGS | Aligos Therapeutics, Inc. Comm | 04/15/2025 | 04/25/2025 | 20.31% | 4,097,451 | 831,999 | 245,352 | 3.39 | |
ALGS | Aligos Therapeutics, Inc. Comm | 03/31/2025 | 04/09/2025 | 20.10% | 4,097,451 | 823,551 | 114,395 | 7.2 | |
ALGS | Aligos Therapeutics, Inc. Comm | 03/14/2025 | 03/25/2025 | 19.41% | 4,097,451 | 795,342 | 187,092 | 4.25 | |
ALGS | Aligos Therapeutics, Inc. Comm | 02/28/2025 | 03/11/2025 | 32.14% | 2,247,339 | 722,352 | 204,826 | 3.53 | |
ALGS | Aligos Therapeutics, Inc. Comm | 02/14/2025 | 02/26/2025 | 31.73% | 2,247,339 | 712,993 | 275,388 | 2.59 | |
ALGS | Aligos Therapeutics, Inc. Comm | 01/31/2025 | 02/11/2025 | 25.65% | 2,247,339 | 576,358 | 251,513 | 2.29 | |
ALGS | Aligos Therapeutics, Inc. Comm | 01/15/2025 | 01/27/2025 | 29.56% | 2,247,339 | 664,384 | 427,046 | 1.56 | |
ALGS | Aligos Therapeutics, Inc. Comm | 12/31/2024 | 01/10/2025 | 26.58% | 2,247,339 | 597,297 | 485,625 | 1.23 | |
ALGS | Aligos Therapeutics, Inc. Comm | 12/13/2024 | 12/24/2024 | 20.34% | 2,247,339 | 457,104 | 416,785 | 1.1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 11/29/2024 | 12/10/2024 | 12.63% | 2,247,339 | 283,759 | 549,475 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 11/15/2024 | 11/26/2024 | 12.97% | 2,247,339 | 291,505 | 680,379 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 10/31/2024 | 11/11/2024 | 5.40% | 2,247,339 | 121,295 | 171,200 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 10/15/2024 | 10/24/2024 | 4.46% | 1,855,549 | 82,817 | 47,191 | 1.75 | |
ALGS | Aligos Therapeutics, Inc. Comm | 09/30/2024 | 10/09/2024 | 6.47% | 1,855,549 | 120,036 | 150,976 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 09/13/2024 | 09/24/2024 | 1.87% | 1,855,549 | 34,726 | 120,884 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 08/30/2024 | 09/11/2024 | 0.81% | 1,855,549 | 14,940 | 29,581 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 08/15/2024 | 08/26/2024 | 16.95% | 1,855,549 | 314,489 | 538,520 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 07/31/2024 | 08/09/2024 | 0.61% | 46,388,746 | 281,115 | 208,474 | 1.35 | |
ALGS | Aligos Therapeutics, Inc. Comm | 07/15/2024 | 07/24/2024 | 0.56% | 44,596,106 | 248,496 | 757,400 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 06/28/2024 | 07/10/2024 | 4.83% | 44,596,106 | 2,155,069 | 735,877 | 2.93 | |
ALGS | Aligos Therapeutics, Inc. Comm | 06/14/2024 | 06/26/2024 | 4.16% | 44,596,106 | 1,854,535 | 232,717 | 7.97 | |
ALGS | Aligos Therapeutics, Inc. Comm | 05/31/2024 | 06/11/2024 | 4.16% | 44,596,106 | 1,856,381 | 275,019 | 6.75 | |
ALGS | Aligos Therapeutics, Inc. Comm | 05/15/2024 | 05/24/2024 | 2.47% | 44,596,106 | 1,100,764 | 169,876 | 6.48 | |
ALGS | Aligos Therapeutics, Inc. Comm | 04/30/2024 | 05/09/2024 | 1.88% | 44,596,106 | 838,464 | 225,715 | 3.71 | |
ALGS | Aligos Therapeutics, Inc. Comm | 04/15/2024 | 04/24/2024 | 1.56% | 42,154,700 | 657,205 | 355,766 | 1.85 | |
ALGS | Aligos Therapeutics, Inc. Comm | 03/28/2024 | 04/09/2024 | 1.27% | 68,620,153 | 868,831 | 350,399 | 2.48 | |
ALGS | Aligos Therapeutics, Inc. Comm | 03/15/2024 | 03/26/2024 | 0.53% | 68,620,153 | 365,600 | 611,685 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 02/29/2024 | 03/11/2024 | 0.54% | 68,620,153 | 369,070 | 713,027 | 1 | |
ALGS | Aligos Therapeutics, Inc. Comm | 02/15/2024 | 02/27/2024 | 0.47% | 68,048,538 | 317,126 | 152,364 | 2.08 | |
ALGS | Aligos Therapeutics, Inc. Comm | 01/31/2024 | 02/09/2024 | 1.31% | 68,048,538 | 894,474 | 190,974 | 4.68 | |
ALGS | Aligos Therapeutics, Inc. Comm | 01/12/2024 | 01/24/2024 | 1.24% | 67,883,480 | 840,417 | 186,158 | 4.51 | |
ALGS | Aligos Therapeutics, Inc. Comm | 12/29/2023 | 01/10/2024 | 1.26% | 67,883,480 | 855,208 | 614,247 | 1.39 | |
ALGS | Aligos Therapeutics, Inc. Comm | 12/15/2023 | 12/27/2023 | 1.27% | 67,883,480 | 864,431 | 648,956 | 1.33 | |
ALGS | Aligos Therapeutics, Inc. Comm | 11/30/2023 | 12/11/2023 | 1.12% | 67,883,480 | 756,938 | 50,146 | 15.09 | |
ALGS | Aligos Therapeutics, Inc. Comm | 11/15/2023 | 11/27/2023 | 1.07% | 67,883,480 | 724,809 | 127,988 | 5.66 |
In cerca di azioni più vendute allo scoperto?